2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
13
Breast Neoplasms
13
Obesity
8
Motor Activity
7
Malnutrition
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Overweight
5
Weight Loss
4
Hypertension
4
Stroke
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Heart Failure
3
Diabetes Mellitus
3
Cardiovascular Diseases
3
Sarcopenia
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Osteoporosis
2
Kidney Diseases
2
Inflammation
2
Heart Diseases
2
Gastrointestinal Neoplasms
2
Frailty
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
relacorilant
5
Pioglitazone
4
Metformin
4
Sitagliptin Phosphate
3
Resistance Training
3
Dipeptidyl-Peptidase IV Inhibitors
3
saxagliptin
2
Vildagliptin
2
Sulfonylurea Compounds
2
Rosiglitazone
2
Nutritional Status
2
Blood Specimen Collection
2
voglibose
1
somapacitan
1
semaglutide
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
mazdutide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
dapagliflozin
1
alogliptin
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
Nutrition Assessment
×
Clear all
NCT07126587
2025-10-30
HLA
University of North Carolina, Chapel Hill
Phase NA
Recruiting
120 enrolled